Universität zu Köln

Journal Article

Cornely, Oliver A., Miller, Mark A., Fantin, Bruno R., Mullane, Kathleen M., Kean, Yin and Gorbach, Sherwood L. (2013). Is Fidaxomicin the Drug of Choice for Treating Clostridium difficile-Associated Diarrhea in Patients With Cancer? Reply. J. Clin. Oncol., 31 (34). S. 4379 - 4380. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Cornely, Oliver A., Mullane, Kathleen M., Birch, Thomas, Hazan-Steinberg, Sabine, Nathan, Richard, Bouza, Emilio, Calfee, David P., Ellison, Misoo Chung, Wong, Michael T. and Dorr, Mary Beth (2020). Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer. Open Forum Infect. Dis., 7 (2). CARY: OXFORD UNIV PRESS INC. ISSN 2328-8957

Cornely, Oliver A., Mullane, Kathleen M., Ostrosky-Zeichner, Luis, Maher, Rochelle M., Croos-Dabrera, Rodney, Lu, Qiaoyang, Lademacher, Christopher, Perfect, John R., Oren, Ilana, Schmitt-Hoffmann, Anne-Hortense, Giladi, Michael, Marty, Francisco M. ORCID: 0000-0002-3708-8734 and Rahav, Galia (2018). Isavuconazole for treatment of rare invasive fungal diseases. Mycoses, 61 (8). S. 518 - 534. HOBOKEN: WILEY. ISSN 1439-0507

Cornely, Oliver A., Robertson, Michael N., Haider, Shariq, Grigg, Andrew, Geddes, Michelle, Aoun, Mickael, Heinz, Werner J., Raad, Issam, Schanz, Urs, Meyer, Ralf G., Hammond, Sarah P., Mullane, Kathleen M., Ostermann, Helmut, Ullmann, Andrew J., Zimmerli, Stefan, Van Iersel, M. L. P. S., Hepler, Deborah A., Waskin, Hetty, Kartsonis, Nicholas A. and Maertens, Johan (2017). Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. J. Antimicrob. Chemother., 72 (12). S. 3406 - 3414. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091

Marty, Francisco M. ORCID: 0000-0002-3708-8734, Cornely, Oliver A., Mullane, Kathleen M., Ostrosky-Zeichner, Luis, Maher, Rochelle M., Croos-Dabrera, Rodney, Lu, Qiaoyang, Lademacher, Christopher, Oren, Ilana, Schmitt-Hoffmann, Anne-Hortense, Giladi, Michael, Rahav, Galia and Perfect, John R. (2018). Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species. Mycoses, 61 (7). S. 485 - 498. HOBOKEN: WILEY. ISSN 1439-0507

Marty, Francisco M. ORCID: 0000-0002-3708-8734, Ostrosky-Zeichner, Luis, Cornely, Oliver A., Mullane, Kathleen M., Perfect, John R., Thompson, George R., III, Alangaden, George J., Brown, Janice M., Fredricks, David N., Heinz, Werner J., Herbrecht, Raoul ORCID: 0000-0002-9381-4876, Klimko, Nikolai, Klyasova, Galina, Maertens, Johan A., Melinkeri, Sameer R., Oren, Ilana, Pappas, Peter G., Racil, Zdenek, Rahav, Galia, Santos, Rodrigo, Schwartz, Stefan ORCID: 0000-0001-8833-5793, Vehreschild, J. Janne, Young, Jo-Anne H., Chetchotisakd, Ploenchan, Jaruratanasirikul, Sutep, Kanj, Souha S., Engelhardt, Marc, Kaufh, Achim, Ito, Masanori, Lee, Misun, Sasse, Carolyn, Maher, Rochelle M., Zeiher, Bernhardt and Vehreschild, Maria J. G. T. (2016). Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect. Dis., 16 (7). S. 828 - 838. OXFORD: ELSEVIER SCI LTD. ISSN 1474-4457

Perfect, John R., Cornely, Oliver A., Heep, Markus, Ostrosky-Zeichner, Luis, Mullane, Kathleen M., Maher, Rochelle, Croos-Dabrera, Rodney, Lademacher, Christopher, Engelhardt, Marc, Chen, Caroline and Marty, Francisco M. ORCID: 0000-0002-3708-8734 (2018). Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial. Mycoses, 61 (7). S. 420 - 430. HOBOKEN: WILEY. ISSN 1439-0507

Winston, Drew J., Mullane, Kathleen M., Boeckh, Michael J., Cornely, Oliver A., Hurtado, Kimberly, Su, Shu-Chih, Pang, Lei, Zhao, Yanli, Chan, Ivan S. F., Stek, Jon E., Kaplan, Susan S., Parrino, Janie, Annunziato, Paula, Popmihajlov, Zoran and Arvin, Ann (2017). A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of Inactivated Vzv Vaccine (ZVIN) in Recipients of Autologous Hematopoietic Cell Transplants (Auto-Hcts). Biol. Blood Marrow Transplant., 23 (3). S. S22 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-6536

Winston, Drew J., Mullane, Kathleen M., Cornely, Oliver A., Boeckh, Michael J., Brown, Janice Wes, Pergam, Steven A., Trociukas, Igoris, Zak, Pavel, Craig, Michael D., Papanicolaou, Genovefa A., Velez, Juan D., Panse, Jens, Hurtado, Kimberly, Fernsler, Doreen A., Stek, Jon E., Pang, Lei, Su, Shu-Chih, Zhao, Yanli, Chan, Ivan S. F., Kaplan, Susan S., Parrino, Janie, Lee, Ingi, Popmihajlov, Zoran, Annunziato, Paula W. and Arvin, Ann (2018). Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. Lancet, 391 (10135). S. 2116 - 2128. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X